Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 14726 - 14750 of 15130 in total

4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile

Experimental

1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine

Experimental

3-{3-[(DIMETHYLAMINO)METHYL]-1H-INDOL-7-YL}PROPAN-1-OL

Experimental

2-Nonyl-4-quinolinol 1-oxide

Experimental

TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL

Experimental

(1S)-1-AMINO-2-(1H-INDOL-3-YL)ETHANOL

Experimental

GSK-1292263

GSK1292263 has been investigated for the treatment of DIABETES MELLITUS, TYPE 2.
Investigational

Bucindolol

Bucindolol has been investigated in Heart Failure.
Investigational

Indole-3-carbinol

Indole 3 Carbinol is under investigation in clinical trial NCT00033345 (Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer).
Investigational

Iopydol

Experimental

Mepindolol

Mepindolol is a 2-methyl derivative of pindolol. It is a beta blocker.
Experimental

Obidoxime

Experimental

2-amino-8-methyl-4(1H)-quinazolinone

Experimental

ERB-196

Experimental

2-methyl-3,5,7,8-tetrahydro-4H-thiopyrano[4,3-d]pyrimidin-4-one

Experimental

N-[[3-FLUORO-4-ETHOXY-PYRID-2-YL]ETHYL]-N'-[5-CHLORO-PYRIDYL]-THIOUREA

Experimental

6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE

Experimental

4-amino-7,7-dimethyl-7,8-dihydroquinazolin-5(6H)-one

Experimental

4-(3-ethylthiophen-2-yl)benzene-1,2-diol

Experimental

Pimobendan

Vet approved

Piribedil

Piribedil has been investigated in Parkinson's Disease.
Investigational

Dipraglurant

Dipraglurant has been used in trials studying the treatment of Parkinson's Disease. It is a metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator (NAM).
Investigational

RPI-78M

RPI-78M is being developed for the treatment of multiple sclerosis (MS). Other neurological disorders that may be served by RPI-78M include myasthenia gravis (MG), muscular dystrophy (MD) and amyotrophic lateral sclerosis (ALS).
Investigational
Matched Description: … neurological disorders that may be served by RPI-78M include myasthenia gravis (MG), muscular dystrophy (MD) and …

IPH 1101

IPH 1101 is a chemically-synthesized structural analog of non-conventional bacterial phosphoantigens which specifically activate the Vγ9Vδ2 T cell subset. IPH 1101 is the most advanced drug candidate of the γδ T cell platform
Investigational

CX157

CX157,3-fluoro-7-(2,2,2,-trifluoroethoxy)phenoxathiin-10,10-dioxide, is a reversible, selective inhibitor of MAO-A designed to have improved oral bioavailability and reduced clearance compared to previous MAO-A inhibitors of this class.
Investigational
Matched Description: … dioxide, is a reversible, selective inhibitor of MAO-A designed to have improved oral bioavailability and …
Displaying drugs 14726 - 14750 of 15130 in total